Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;100:1112-1115
Published online before print March 29, 2007, doi: 10.1161/01.RES.0000265845.04439.78
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
100/8/1112    most recent
01.RES.0000265845.04439.78v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cho, H. C.
Right arrow Articles by Marbán, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cho, H. C.
Right arrow Articles by Marbán, E.
Related Collections
Right arrow Pacemaker
Right arrow Arrythmias-basic studies
(Circulation Research. 2007;100:1112.)
© 2007 American Heart Association, Inc.


Report

Creation of a Biological Pacemaker by Cell Fusion

Hee Cheol Cho, Yuji Kashiwakura, Eduardo Marbán

From the Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD. Present address for H.C.C.: Excigen Inc, Baltimore, Md. Present address for Y.K.: Okayama Innovation Center for Nanobio-targeted Therapy, School of Medicine, Okayama University, Japan.

Correspondence to Eduardo Marbán, MD, PhD, Chief of Cardiology, 858 Ross Bldg, 720 Rutland Ave, Baltimore, MD 21205. E-mail marban{at}jhmi.edu

As an alternative to electronic pacemakers, we explored the feasibility of converting ventricular myocytes into pacemakers by somatic cell fusion. The idea is to create chemically induced fusion between myocytes and syngeneic fibroblasts engineered to express HCN1 pacemaker channels (HCN1-fibroblasts). HCN1-fibroblasts were fused with freshly isolated guinea pig ventricular myocytes using polyethylene-glycol 1500. In vivo fused myocyte-HCN1-fibroblast cells exhibited spontaneously oscillating action potentials; the firing frequency increased with ß-adrenergic stimulation. The heterokaryons created ectopic ventricular pacemaker activity in vivo at the site of cell injection. Coculture of nonfused HCN1-fibroblasts and myocytes without polyethylene-glycol 1500 revealed no evidence of dye transfer, demonstrating that the If-mediated pacemaker activity arises from heterokaryons rather than electrotonic coupling. This nonviral, non-stem cell approach enables autologous, adult somatic cell therapy to create biopacemakers.


Key Words: arrhythmia • biological pacemaker • cell fusion • cell transplantation • heart rate • ion channels • pacemaker




This article has been cited by other articles:


Home page
Circ Arrhythmia ElectrophysiolHome page
M. R. Rosen, P. R. Brink, I. S. Cohen, and R. B. Robinson
Cardiac Pacing: From Biological to Electronic ... to Biological?
Circ Arrhythmia Electrophysiol, April 1, 2008; 1(1): 54 - 61.
[Abstract] [Full Text] [PDF]